Viewing StudyNCT04224272



Ignite Creation Date: 2024-05-06 @ 2:08 PM
Last Modification Date: 2024-10-26 @ 1:25 PM
Study NCT ID: NCT04224272
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-06
First Post: 2020-01-07

Brief Title: A Study of ZW25 Zanidatamab With Palbociclib Plus Fulvestrant in Patients With HER2HR Advanced Breast Cancer
Sponsor: Jazz Pharmaceuticals
Organization: Jazz Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
HER2HR Breast Cancer
Keywords:
Name View
Fulvestrant View
HER2 View
HR View
Bispecific antibody View
Biparatopic antibody View
Immunotherapy View
Breast cancer View
Chemotherapy View
Palbociclib View